文献速递脑血管病

维生素D与缺血性卒中二级预防的孟德尔随机化分析

Mendelian Randomization Focused Analysis of Vitamin D on the Secondary Prevention of Ischemic Stroke.
PubMed 文献 · Stroke · 2021-09-27

本研究基于维生素D遗传风险评分,在既往有缺血事件的独立亚样本(n=441)中采用两样本个体数据前瞻性孟德尔随机化方法,分析维生素D对复发性缺血性卒中与心肌梗死的影响。结果显示遗传风险评分独立预测复发性缺血性卒中或心肌梗死风险降低,孟德尔随机化支持维生素D对复发事件具有因果保护作用。

要点

  • 遗传预测的维生素D水平降低是既往缺血性卒中或心肌梗死患者缺血性血管事件复发的因果因素。
  • 遗传风险评分独立预测复发性缺血性卒中或心肌梗死联合风险降低(HR 0.62,95%CI 0.48-0.81)。
  • 孟德尔随机化支持维生素D对复发性缺血性卒中或心肌梗死具有因果保护作用。

核心结论

  • 遗传预测的维生素D水平降低对既往缺血性卒中或心肌梗死患者的缺血性血管事件复发具有因果关系。

研究设计与样本

  • 基于推导队列样本(n=5331,45%维生素D缺乏,89%完成基因分型)构建维生素D遗传风险评分,筛选12个既往全基因组关联研究报告的维生素D机制通路遗传变异(rs2060793、rs4588、rs7041;F统计量73;P<0.001)。
  • 在独立缺血性疾病亚样本(n=441,均有既往首次缺血事件;随访41.6±14.3年)中,采用两样本个体数据前瞻性孟德尔随机化方法聚焦分析心肌梗死与缺血性卒中复发。

主要发现

  • 缺血性疾病亚样本中11.1%(49/441)发生复发性缺血性卒中或心肌梗死,13.3%(58/441)发生复发性或新发缺血性卒中/心肌梗死。
  • Kaplan-Meier分析显示遗传风险评分预测复发性缺血性卒中或心肌梗死无事件生存改善(log-rank 13.0;P=0.001)。
  • Cox回归显示校正潜在混杂因素后,遗传风险评分独立预测复发性缺血性卒中或心肌梗死联合风险降低(HR 0.62,95%CI 0.48-0.81;P<0.001)。
  • 孟德尔随机化支持维生素D对主要终点复发性缺血性卒中或心肌梗死具有因果保护作用(Wald估计OR 0.55,95%CI 0.35-0.81),对任何复发性或新发缺血性卒中/心肌梗死(OR 0.64,95%CI 0.42-0.91)及单纯复发性心肌梗死(OR 0.52,95%CI 0.30-0.81)亦具保护作用。

关键数值与推荐

  • 遗传风险评分与复发性缺血性卒中或心肌梗死联合风险:HR 0.62(95%CI 0.48-0.81),P<0.001。
  • 孟德尔随机化Wald估计:复发性缺血性卒中或心肌梗死OR 0.55(95%CI 0.35-0.81);任何复发性或新发缺血性卒中/心肌梗死OR 0.64(95%CI 0.42-0.91);单纯复发性心肌梗死OR 0.52(95%CI 0.30-0.81)。

临床怎么用

  • 对既往有缺血性卒中或心肌梗死的患者,遗传预测的维生素D水平降低提示缺血性血管事件复发风险升高,支持关注维生素D状态作为二级预防的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Experimental studies showed vitamin D (Vit-D) could promote vascular regeneration and repair. Prior randomized studies had focused mainly on primary prevention. Whether Vit-D protects against ischemic stroke and myocardial infarction recurrence among subjects with prior ischemic insults was unknown. Here, we dissected through Mendelian randomization any effect of Vit-D on the secondary prevention of recurrent ischemic stroke and myocardial infarction. METHODS: Based on a genetic risk score for Vit-D constructed from a derivation cohort sample (n=5331, 45% Vit-D deficient, 89% genotyped) via high-throughput exome-chip screening of 12 prior genome-wide association study-identified genetic variants of Vit-D mechanistic pathways (rs2060793, rs4588, and rs7041; F statistic, 73; P<0.001), we performed a focused analysis on prospective recurrence of myocardial infarction (MI) and ischemic stroke in an independent subsample with established ischemic disease (n=441, all with prior first ischemic event; follow-up duration, 41.6±14.3 years) under a 2-sample, individual-data, prospective Mendelian randomization approach. RESULTS: In the ischemic disease subsample, 11.1% (n=49/441) had developed recurrent ischemic stroke or MI and 13.3% (n=58/441) had developed recurrent or de novo ischemic stroke/MI. Kaplan-Meier analyses showed that genetic risk score predicted improved event-free survival from recurrent ischemic stroke or MI (log-rank, 13.0; P=0.001). Cox regression revealed that genetic risk score independently predicted reduced risk of recurrent ischemic stroke or MI combined (hazards ratio, 0.62 [95% CI, 0.48-0.81]; P<0.001), after adjusted for potential confounders. Mendelian randomization supported that Vit-D is causally protective against the primary end points of recurrent ischemic stroke or MI (Wald estimate: odds ratio, 0.55 [95% CI, 0.35-0.81]) and any recurrent or de novo ischemic stroke/MI (odds ratio, 0.64 [95% CI, 0.42-0.91]) and recurrent MI alone (odds ratio, 0.52 [95% CI, 0.30-0.81]). CONCLUSIONS: Genetically predicted lowering in Vit-D level is causal for the recurrence of ischemic vascular events in persons with prior ischemic stroke or MI.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chan YH, Schooling CM, Zhao J, et al. Mendelian Randomization Focused Analysis of Vitamin D on the Secondary Prevention of Ischemic Stroke. Stroke. 2021. PMID: 34565175. doi:10.1161/STROKEAHA.120.032634

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。